Journal ArticleOpen Access
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study
Authors
Author Affiliations
University of Ulster, Belfast City Hospital, United BioSource Corporation (United Kingdom), Novartis (Netherlands), ...
Published InEuropean Respiratory Journal
Year2012
Citations58
Abstract
The aim of our study was to discover the health status and healthcare utilisation associated with pulmonary exacerbations in cystic fibrosis (CF) and chronic Pseudomonas aeruginosa infection. Patients with CF from five UK CF centres attended two visits, 8-12 weeks apart. They were classified at visit 1 as being in one of the three health states: no current pulmonary exacerbation; "mild" (no hospitalisation) pulmonary exacerbation; and "severe" (hospitalisation) pulmonary exacerbation. All patients completed the Cystic Fibrosis Questionnaire-Revised (CFQ-R) and EuroQol (EQ-5D) and a clinical form, and forced expiratory volume in 1 s (FEV1) was measured at visits 1 and 2. Annual healthcare utilisation data were collected. 94 patients of mean±sd age 28.5±8.2 yrs and FEV1 58.7±26.8% were recruited. 60 patients…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.